In the development of peptide drugs for reproductive endocrinology and tumor treatment, GnRH antagonists have attracted much attention due to their precise regulatory advantages. Today, we would like to share with you a core molecule—antipeptide acetate (CAS: 112568-12-4), whose unique structural design and clear mechanism of action have demonstrated significant application value in multiple studies.
As a highly selective GnRH antagonist, antipeptide acetate's core advantage lies in its competitive binding to GnRH receptors, which can rapidly inhibit the release of gonadotropins (FSH/LH) and downregulate sex hormone levels. Unlike traditional GnRH agonists, which may cause a surge in hormone levels initially, it achieves stable regulation, a characteristic that makes it a key focus of clinical translational research.
Studies have shown that, through D-amino acid modification and cyclic structure design, antipeptide acetate has a plasma half-life of 12-16 hours, far exceeding the 2-3 minutes of natural GnRH, significantly improving the convenience of clinical application (ChemBook, 2025). In the field of reproductive medicine, related experiments have confirmed its effective regulation of ovulation cycles and significant improvement in oocyte retrieval success rates in assisted reproduction. In the treatment of hormone-dependent tumors, mouse model studies have shown that after 6 weeks of intervention, tumor volume can be reduced by 75%, providing new insights for targeted therapy of diseases such as prostate cancer and breast cancer.
Beyond the fields of reproduction and oncology, antipeptide acetate has also shown potential in the treatment of gynecological diseases such as endometriosis and uterine fibroids. Its mechanism of action is related to the highly specific binding of GnRH receptors, inhibiting the proliferation of diseased tissue and alleviating clinical symptoms by reducing sex hormone levels. This pathway has been validated in multiple basic studies (ChemBook, 2025).
From a scientific research application perspective, the basic parameters of antitide acetate are well-defined: its molecular formula is C82H108ClN17O14, its molecular weight is 1591.29, and it is a white to off-white solid that needs to be stored in a sealed container at -20°C. Currently, it is widely used as a research reagent, in preclinical studies, and in drug development, providing a reliable tool for exploring the mechanisms in related fields.
With the advancement of precision medicine, the research and optimization of GnRH antagonists continues to deepen. Antitide acetate, with its stable efficacy and broad compatibility, is becoming an important bridge connecting basic research and clinical applications.
